15 Jan 2021
// PRESS RELEASE
05 Oct 2020
// PRESS RELEASE
12 Jun 2020
// PRESS RELEASE
Latest Content by PharmaCompass
KEY PRODUCTS
KEY SERVICESCayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
About
Chemspec EuropeChemspec Europe
Industry Trade Show
Attending
06-07 May, 2026
CPhI Middle EastCPhI Middle East
Industry Trade Show
Attending
11-13 May, 2026
CDMO Live Europe 2026CDMO Live Europe 2026
Industry Trade Show
Attending
19-21 May, 2026
CONTACT DETAILS





Events
Webinars & Exhibitions
Chemspec EuropeChemspec Europe
Industry Trade Show
Attending
06-07 May, 2026
CPhI Middle EastCPhI Middle East
Industry Trade Show
Attending
11-13 May, 2026
CDMO Live Europe 2026CDMO Live Europe 2026
Industry Trade Show
Attending
19-21 May, 2026
VLOG #PharmaReel
CORPORATE CONTENT #SupplierSpotlight

15 Jan 2021
// PRESS RELEASE
https://www.pharmacompass.com/pdf/news/chemist-with-a-passion-for-technology-30802.pdf

https://www.pharmacompass.com/pdf/news/pavel-bartko-one-security-guard-will-not-solve-work-safety-as-a-soldier-himself-in-the-field-he-must-have-the-support-of-employees-69499.pdf

12 Jun 2020
// PRESS RELEASE

07 May 2020
// PRESS RELEASE

27 Mar 2020
// PRESS RELEASE

26 Feb 2020
// PRESS RELEASE
https://www.pharmacompass.com/pdf/news/what-to-attract-employees-to-the-key-is-quality-product-and-flexibility-45354.pdf
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-12
Pay. Date : 2013-02-11
DMF Number : 24353
Submission : 2011-01-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-27
Pay. Date : 2019-09-13
DMF Number : 21584
Submission : 2008-04-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-17
Pay. Date : 2016-11-10
DMF Number : 26081
Submission : 2012-05-14
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-10
Pay. Date : 2013-08-16
DMF Number : 17445
Submission : 2004-06-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-01-24
Pay. Date : 2023-04-27
DMF Number : 37429
Submission : 2023-05-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-15
Pay. Date : 2021-04-06
DMF Number : 35765
Submission : 2021-04-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-08
DMF Number : 22289
Submission : 2008-12-08
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Certificate Numbers : CEP 2023-147 - Rev 01
Status : Valid
Issue Date : 2025-09-23
Type : Chemical
Substance Number : 2230
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Certificate Numbers : CEP 2022-093 - Rev 01
Status : Valid
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 2230
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registration Number : 221MF10112
Registrant's Address : ul. Pra(´)ce 657,277 11 Neratovice, Czech Republic
Initial Date of Registration : 2009-06-10
Latest Date of Registration : 2018-10-26
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registration Number : 221MF10182
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2009-08-13
Latest Date of Registration : 2009-08-13
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registration Number : 220MF10211
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2008-10-10
Latest Date of Registration : 2008-10-10
Registration Number : 302MF10040
Registrant's Address : ul. Pra(´)ce, 657, 277 11 Neratovice, Czech Republic
Initial Date of Registration : 2020-04-02
Latest Date of Registration : 2020-04-02
Registration Number : 227MF10153
Registrant's Address : ul. Pra(´)ce 657,277 11 Neratovice, Czech Republic
Initial Date of Registration : 2015-06-01
Latest Date of Registration : 2022-09-14
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registrant Name : Eltech Pharmachem Co., Ltd.
Registration Date : 2021-11-23
Registration Number : Su469-4-ND
Manufacturer Name : Cayman Pharma sro
Manufacturer Address : Ul. Práce 657, 277 11 Neratovice, Czech Republic
Registrant Name : Eltech Pharmachem Co., Ltd.
Registration Date : 2022-01-24
Registration Number : 20220124-211-J-1221
Manufacturer Name : Cayman Pharma sro
Manufacturer Address : ul. Práce 657 277 11 Neratovice
Registrant Name : Clasia Co., Ltd.
Registration Date : 2024-01-15
Registration Number : Su758-10-ND
Manufacturer Name : Cayman Pharma sro
Manufacturer Address : Práce 657, 277 11 Neratovice, Czech Republic
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registrant Name : Santen Korea Co., Ltd.
Registration Date : 2023-11-20
Registration Number : Su139-6-ND
Manufacturer Name : Cayman Chemical Company
Manufacturer Address : 1180 E. Ellsworth Road Ann Arbor, MI 48108 USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 61556-070
Start Marketing Date : 2015-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61556-001
Start Marketing Date : 2003-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61556-030
Start Marketing Date : 2011-04-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
About the Company : Cayman Pharma is a leading European provider of cGMP prostaglandin APIs, created in 2006 from the merger of Cayman Chemical and NeraPharm, combining deep prostaglandin chemistry expertise. With ...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Lead Product(s): KMN-159,Collagen
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Miscellaneous
Sponsor: NIDCR
Deal Size: $1.7 million Upfront Cash: Undisclosed
Deal Type: Funding September 16, 2021
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 16, 2021
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Undisclosed
Sponsor: SBIR
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Funding October 08, 2020
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : SBIR
Deal Size : Undisclosed
Deal Type : Funding
Cayman Receives SBIR Grant for Alzheimer’s Research
Details : The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 08, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Services
Analytical
API Manufacturing
Pharma Service : API Manufacturing
Category : GMP Manufacturing
Sub Category : Active Pharmaceutical Ingredients
Pharma Service : API Manufacturing
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Overview
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Custom Synthesis
Pharma Service : API & Drug Product Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Inspections and registrations
Country : Czech Republic
City/Region : Neratovice
Audit Date : 2023-09-18
Audit Type : On-Site
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Cayman Pharma s.r.o is a supplier offers 8 products (APIs, Excipients or Intermediates).
Find a price of Latanoprost bulk with DMF, CEP, JDMF offered by Cayman Pharma s.r.o
Find a price of Epoprostenol Sodium bulk with DMF, JDMF offered by Cayman Pharma s.r.o
Find a price of Travoprost bulk with DMF, JDMF offered by Cayman Pharma s.r.o
Find a price of Bimatoprost bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Latanoprostene Bunod bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Tafluprost bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Cloprostenol Sodium bulk offered by Cayman Pharma s.r.o
Find a price of Psilocybine bulk offered by Cayman Pharma s.r.o
Cayman Pharma S.r.o



